171 related articles for article (PubMed ID: 8352988)
1. [Myocardial fibrosis--the theoretical bases, clinical aspects and therapeutic implications].
Perdigão C
Rev Port Cardiol; 1993; 12(7-8):675-85, 603. PubMed ID: 8352988
[TBL] [Abstract][Full Text] [Related]
2. [Spironolactone: renaissance of anti-aldosterone therapy in heart failure?].
Brilla CG; Schencking M; Scheer C; Rupp H
Praxis (Bern 1994); 1997 Apr; 86(14):566-74. PubMed ID: 9198851
[TBL] [Abstract][Full Text] [Related]
3. [Left-ventricular hypertrophy as a cardiac risk factor: role of the renin-angiotensin-aldosterone system].
Erne P
Praxis (Bern 1994); 1996 Feb; 85(8):227-33. PubMed ID: 8701189
[TBL] [Abstract][Full Text] [Related]
4. Effects of ACE inhibition versus non-ACE inhibitor antihypertensive treatment on myocardial fibrosis in patients with arterial hypertension. Retrospective analysis of 120 patients with left ventricular endomyocardial biopsies.
Brilla CG; Rupp H; Maisch B
Herz; 2003 Dec; 28(8):744-53. PubMed ID: 14689110
[TBL] [Abstract][Full Text] [Related]
5. Myocardial fibrosis and the renin-angiotensin-aldosterone system.
Weber KT; Brilla CG
J Cardiovasc Pharmacol; 1992; 20 Suppl 1():S48-54. PubMed ID: 1380619
[TBL] [Abstract][Full Text] [Related]
6. Renin-angiotensin system and myocardial fibrosis in hypertension: regulation of the myocardial collagen matrix.
Brilla CG; Reams GP; Maisch B; Weber KT
Eur Heart J; 1993 Nov; 14 Suppl J():57-61. PubMed ID: 8281964
[TBL] [Abstract][Full Text] [Related]
7. Role of angiotensin-converting enzyme inhibitors, angiotensin II receptor blockers, and aldosterone antagonists in the prevention of atrial and ventricular arrhythmias.
Makkar KM; Sanoski CA; Spinler SA
Pharmacotherapy; 2009 Jan; 29(1):31-48. PubMed ID: 19113795
[TBL] [Abstract][Full Text] [Related]
8. Cardiac consequences of aldosterone excess in human hypertension.
Rossi GP
Am J Hypertens; 2006 Jan; 19(1):10-2. PubMed ID: 16461183
[No Abstract] [Full Text] [Related]
9. Role of aldosterone in left ventricular hypertrophy in hypertension.
Matsumura K; Fujii K; Oniki H; Oka M; Iida M
Am J Hypertens; 2006 Jan; 19(1):13-8. PubMed ID: 16461184
[TBL] [Abstract][Full Text] [Related]
10. Cardiac remodelling by fibrous tissue: role of local factors and circulating hormones.
Sun Y; Weber KT
Ann Med; 1998 Aug; 30 Suppl 1():3-8. PubMed ID: 9800877
[TBL] [Abstract][Full Text] [Related]
11. Anti-aldosterone treatment and the prevention of myocardial fibrosis in primary and secondary hyperaldosteronism.
Brilla CG; Matsubara LS; Weber KT
J Mol Cell Cardiol; 1993 May; 25(5):563-75. PubMed ID: 8377216
[TBL] [Abstract][Full Text] [Related]
12. [Pathophysiology of left ventricular hypertrophy in arterial hypertension].
Vallotton MB; Braconi-Quintaje S; Lang U
Praxis (Bern 1994); 1997 Feb; 86(7):234-7. PubMed ID: 9139339
[TBL] [Abstract][Full Text] [Related]
13. Left ventricular and microvascular hypertrophy in essential hypertension: clinical relevance and prognostic implications.
Thürmann PA
Int J Clin Pharmacol Ther; 1997 May; 35(5):181-7. PubMed ID: 9174872
[TBL] [Abstract][Full Text] [Related]
14. Role of aldosterone in angiotensin II-induced cardiac and aortic inflammation, fibrosis, and hypertrophy.
Neves MF; Amiri F; Virdis A; Diep QN; Schiffrin EL;
Can J Physiol Pharmacol; 2005 Nov; 83(11):999-1006. PubMed ID: 16391708
[TBL] [Abstract][Full Text] [Related]
15. Aldosterone inhibition limits collagen synthesis and progressive left ventricular enlargement after anterior myocardial infarction.
Modena MG; Aveta P; Menozzi A; Rossi R
Am Heart J; 2001 Jan; 141(1):41-6. PubMed ID: 11136485
[TBL] [Abstract][Full Text] [Related]
16. Cardioprotection by aldosterone receptor antagonism in heart failure. Part I. The role of aldosterone in heart failure.
Dieterich HA; Wendt C; Saborowski F
Fiziol Cheloveka; 2005; 31(6):97-105. PubMed ID: 16366159
[TBL] [Abstract][Full Text] [Related]
17. [Myocardial hypertrophy and fibrosis. New connections with the renin-angiotensin-aldosterone system].
Karlberg BE
Lakartidningen; 1993 Jan; 90(1-2):35-6. PubMed ID: 8421400
[No Abstract] [Full Text] [Related]
18. Targeting the calpain/calpastatin system as a new strategy to prevent cardiovascular remodeling in angiotensin II-induced hypertension.
Letavernier E; Perez J; Bellocq A; Mesnard L; de Castro Keller A; Haymann JP; Baud L
Circ Res; 2008 Mar; 102(6):720-8. PubMed ID: 18258859
[TBL] [Abstract][Full Text] [Related]
19. Role of the renin-angiotensin-aldosterone system in vascular remodeling and inflammation: a clinical review.
Duprez DA
J Hypertens; 2006 Jun; 24(6):983-91. PubMed ID: 16685192
[TBL] [Abstract][Full Text] [Related]
20. [Ventricular arrhythmias and arterial hypertension].
Dorobantu M; Galinier M; Bounhoure JP
Ann Cardiol Angeiol (Paris); 1996 May; 45(5):291-5. PubMed ID: 8763649
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
